Rationing Scarce Resources: The Potential Impact of COVID-19 on Patients with Chronic Kidney Disease

Jeffrey Silberzweig; T. Alp Ikizler; Holly Kramer; Paul M. Palevsky; Joseph Vassalotti; Alan S. Kliger

doi:10.1681/ASN.2020050704

Rationing Scarce Resources: The Potential Impact of COVID-19 on Patients with Chronic Kidney Disease

Jeffrey Silberzweig
, T. Alp Ikizler
, Holly Kramer
, Paul M. Palevsky
, Joseph Vassalotti
, Alan S. Kliger

Research output: Contribution to journal › Review article › peer-review

12 Scopus citations

Original language	English
Pages (from-to)	1926-1928
Number of pages	3
Journal	Journal of the American Society of Nephrology
Volume	31
Issue number	9
DOIs	https://doi.org/10.1681/ASN.2020050704
State	Published - Sep 2020

Access to Document

10.1681/ASN.2020050704

Cite this

@article{e734e394a58d4261830f3b7f91efa2fa,

title = "Rationing Scarce Resources: The Potential Impact of COVID-19 on Patients with Chronic Kidney Disease",

author = "Jeffrey Silberzweig and \{Alp Ikizler\}, T. and Holly Kramer and Palevsky, \{Paul M.\} and Joseph Vassalotti and Kliger, \{Alan S.\}",

note = "Funding Information: Dr. T. Alp Ikizler reports personal fees from Fresenius Kabi, personal fees from International Society of Nephrology, and personal fees from Abbott Renal Care, outside the submitted work. Dr. Paul M. Palevsky reports personal fees from Baxter and grants from BioPorto and Dascena, outside the submitted work.",

year = "2020",

month = sep,

doi = "10.1681/ASN.2020050704",

language = "English",

volume = "31",

pages = "1926--1928",

journal = "Journal of the American Society of Nephrology",

issn = "1046-6673",

publisher = "Wolters Kluwer Health",

number = "9",

}

TY - JOUR

T1 - Rationing Scarce Resources

T2 - The Potential Impact of COVID-19 on Patients with Chronic Kidney Disease

AU - Silberzweig, Jeffrey

AU - Alp Ikizler, T.

AU - Kramer, Holly

AU - Palevsky, Paul M.

AU - Vassalotti, Joseph

AU - Kliger, Alan S.

N1 - Funding Information: Dr. T. Alp Ikizler reports personal fees from Fresenius Kabi, personal fees from International Society of Nephrology, and personal fees from Abbott Renal Care, outside the submitted work. Dr. Paul M. Palevsky reports personal fees from Baxter and grants from BioPorto and Dascena, outside the submitted work.

PY - 2020/9

Y1 - 2020/9

UR - https://www.scopus.com/pages/publications/85090175874

U2 - 10.1681/ASN.2020050704

DO - 10.1681/ASN.2020050704

M3 - Review article

C2 - 32669321

AN - SCOPUS:85090175874

SN - 1046-6673

VL - 31

SP - 1926

EP - 1928

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

IS - 9

ER -